— Know what they know.
Not Investment Advice

BGM NASDAQ

BGM Group Ltd.
1W: +29.7% 1M: +11.3% 3M: -17.4% YTD: -91.3% 1Y: -97.0%
$9.34
+1.52 (+19.44%)
 
Weekly Expected Move ±11.8%
$7 $8 $9 $10 $12
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 40 · $118.5M mcap · 3M float · 13.07% daily turnover · Short 42% of daily vol

Income Trends

Revenue
$25M -46.0% ▼
5Y CAGR: -11.4%
Gross Profit
$4M +134.9% ▲
5Y CAGR: -15.7%
Operating Income
-$564K +78.4% ▲
Net Income
-$1M +81.5% ▲
EPS (Diluted)
$-0.20 +81.5% ▲
EBITDA
$880K +169.0% ▲
5Y CAGR: -36.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$50M$57M$65M$46M$25M
YoY Growth+8.5%+14.1%+13.6%-28.3%-46.0%
Cost of Revenue$42M$51M$59M$45M$21M
Gross Profit$8M$6M$6M$2M$4M
Gross Margin15.1%9.9%9.6%3.8%16.4%
R&D Expenses$0$0$1M$568K$1M
SG&A Expenses$3M$3M$3M$4M$3M
Operating Expenses$3M$3M$4M$4M$5M
Operating Income$5M$2M$2M-$3M-$564K
Operating Margin9.6%4.2%3.2%-5.6%-2.2%
Interest Expense$243K$58K$0$0$640K
Income Before Tax$6M$3M$2M-$8M-$2M
Tax Expense$865K$255K$194K$219K-$620K
Net Income$5M$3M$1M-$8M-$1M
Net Margin10.1%5.5%1.7%-16.7%-5.7%
EPS (Diluted)$0.72$0.45$0.15$-1.08$-0.20
EBITDA$7M$4M$4M-$1M$880K
Shares Outstanding7M7M7M7M7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms